Hexestrol Hexestrol
Structural formula
Business number | 01UG |
---|---|
Molecular formula | C18H22O2 |
Molecular weight | 270.37 |
label |
4,4′-(1,2-diethylethylene)diphenol, hexestrol, 4,4′-(1,2-Diethylethylene)diphenol, meso-3,4-Bis(4-hydroxyphenyl)hexane, Dihydrodiethylstilbestrol, [CH(C2H5)C6H4OH]2 |
Numbering system
CAS number:84-16-2
MDL number:MFCD00068996
EINECS number:201-518-1
RTECS number:SL0560850
BRN number:3209460
PubChem number:24895805
Physical property data
1. Properties: White, odorless crystalline powder.
2. Density (g/mL ,25/4℃):Undetermined
3. Relative vapor density (g /mL,AIR= 1): Undetermined
4. Melting point (ºC):186℃
5. Boiling point (ºC,Normal pressure): Undetermined
6. Boiling point (ºC,5.2 kPa): Undetermined
7. Refractive Index: Undetermined
8. Flash point (ºC): Undetermined
9. Specific optical rotation (º ): Undetermined
10. Autoignition point or ignition temperature (ºC): Undetermined
11. Vapor pressure (kPa, 25ºC): Undetermined
10. Number of isotope atoms: 0
11. Determine atoms Number of stereocenters:0
12. Not sure Number of atomic stereocenters:0
13. Determine chemical bonds Number of stereocenters:0
14. Not sure Number of stereocenters of chemical bonds:0
15. Covalent Number of key units:1
Properties and stability
None yet
Storage method
Avoid light and store in an airtight container.
Synthesis method
Made from anethole.
Purpose
It is an estrogen drug that can promote the development of sexual organs and secondary sexual characteristics, the proliferation and shedding of uterine mucosa, and form cyclic menstruation; it inhibits the production of anterior pituitary gonadotropins and Prolactin is released, antagonizing androgens. It is suitable for uterine hypoplasia, functional uterine bleeding, amenorrhea, menopausal syndrome, reduced milk secretion, prostate cancer, etc. Preparations include tablets and injections.
anguage: EN-US; mso-fareast-language: ZH-CN; mso-bidi-language: AR-SA”>Made from anethole as raw material.
Purpose
It is an estrogen drug that can promote the development of sexual organs and secondary sexual characteristics, the proliferation and shedding of uterine mucosa, and form cyclic menstruation; it inhibits the production of anterior pituitary gonadotropins and Prolactin is released, antagonizing androgens. It is suitable for uterine hypoplasia, functional uterine bleeding, amenorrhea, menopausal syndrome, reduced milk secretion, prostate cancer, etc. Preparations include tablets and injections.